| Literature DB >> 20533364 |
Shannon K Gallagher1, Paul Witkovsky, Michel J Roux, Malcolm J Low, Veronica Otero-Corchon, Shane T Hentges, Jozsef Vigh.
Abstract
Evidence showing expression of endogenous opioids in the mammalian retina is sparse. In the present study we examined a transgenic mouse line expressing an obligate dimerized form of Discosoma red fluorescent protein (DsRed) under the control of the pro-opiomelanocortin promoter and distal upstream regulatory elements to assess whether pro-opiomelanocortin peptide (POMC), and its opioid cleavage product, beta-endorphin, are expressed in the mouse retina. Using double label immunohistochemistry we found that DsRed fluorescence was restricted to a subset of GAD-67-positive cholinergic amacrine cells of both orthotopic and displaced subtypes. About 50% of cholinergic amacrine cells colocalized DsRed and a large fraction of DsRed-expressing amacrine cells was positive for beta-endorphin immunostaining, whereas beta-endorphin-immunoreactive neurons were absent in retinas of POMC null mice. Our findings contribute to a growing body of evidence demonstrating that opioid peptides are an integral component of vertebrate retinas, including those of mammals. (c) 2010 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20533364 PMCID: PMC3095846 DOI: 10.1002/cne.22387
Source DB: PubMed Journal: J Comp Neurol ISSN: 0021-9967 Impact factor: 3.215